- Filed
- Nov 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Nov 19, 2025 | 384.93M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 384.9M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2024 | 352.34M sh |
| Operating Cash Flow | Q1 2026 · Sep 30, 2025 | −$182.79K |
| Operating Cash Flow | Q1 2026 · Sep 30, 2024 | −$410.25K |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $4.72M |
| Stockholders Equity | Q1 2026 · Jun 30, 2025 | $5.37M |
| Stockholders Equity restated | Q1 2026 · Sep 30, 2024 | $7.01M |
| Stockholders Equity | Q1 2026 · Jun 30, 2024 | $7.68M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $12.81M |
| Current Liabilities | Q1 2026 · Jun 30, 2025 | $12.01M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $12.9M |
| Total Liabilities | Q1 2026 · Jun 30, 2025 | $12.12M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $12.35M |
| Current Assets | Q1 2026 · Jun 30, 2025 | $12.16M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $17.62M |
| Total Assets | Q1 2026 · Jun 30, 2025 | $17.49M |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Sep 30, 2024 | $0.00 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Sep 30, 2024 | $0.00 |
| Sga Expense | Q1 2026 · Sep 30, 2025 | $702.38K |
| Sga Expense | Q1 2026 · Sep 30, 2024 | $649.07K |
| Net Income | Q1 2026 · Sep 30, 2025 | −$651.55K |
| Net Income | Q1 2026 · Sep 30, 2024 | −$694.07K |
| Operating Income | Q1 2026 · Sep 30, 2025 | −$639.47K |
| Operating Income | Q1 2026 · Sep 30, 2024 | −$666.87K |
| Revenue | Q1 2026 · Sep 30, 2025 | $95.2K |
| Revenue | Q1 2026 · Sep 30, 2024 | $44.12K |
| Capex | Q1 2026 · Sep 30, 2024 | $101.38K |